Compounding legality by state

Compounding rules for GLP-1 medications shift by jurisdiction and change without warning. Pick your state to see the current status for each drug and compounding type, with sources and last-reviewed dates.

What this currently reflects: the federal compounding framework — 503A patient-specific rules, 503B outsourcing rules, and FDA shortage status — which sets the floor in every state. State-level pharmacy-board guidance and telehealth-prescribing rules are being layered in and are noted where we have them. Informational only, not legal advice.